Complement C3 is a novel plasma clot component with anti-fibrinolytic properties

Interactions between factor XIII and the  C region of fibrinogen

(2011) K. A. Smith et al.   BLOOD

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

(2011) K. Hess et al.   DIABETOLOGIA

Proinflammatory and hypofibrinolytic phenotype in healthy first-degree relatives of patients with Type 2 diabetes

(2010) V. SCHROEDER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Fibrin formation and lysis studies in dengue virus infection

(2009) Rita Marchi et al.   BLOOD COAGULATION & FIBRINOLYSIS

Proteomic Analysis of IgE-Mediated Secretion by LAD2 Mast Cells

(2009) Matthew C. Gage et al.   JOURNAL OF PROTEOME RESEARCH

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

Complement C3 and C-reactive protein in male survivors of myocardial infarction

(2008) Angela M. Carter et al.   ATHEROSCLEROSIS

The human fibrinolytic system is a target for the staphylococcal metalloprotease aureolysin

(2008) Nathalie Beaufort et al.   BIOCHEMICAL JOURNAL

Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity

(2008) J. B. WALKER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication

(2008) Neeraj Bhasin et al.   JOURNAL OF VASCULAR SURGERY